You are here

NPS Pharmaceuticals, Inc.

Company Information
Address 104 MEDICAL RESEARCH BLDG
Salt Lake City, UT, 84108


Information

DUNS:

# of Employees: N/A


Ownership Information

HUBZone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. PERIVASCULAR CA+ RECEPTOR--THERAPEUTIC SIGNIFICANCE

    Amount: $100,000.00

    N/A

    STTRPhase I1998Department of Health and Human Services
  2. Novel NMDA Antagonists Lacking PCP Like Side Effects

    Amount: $75,817.00

    NMDA receptor antagonists may possess therapeutic utility for a variety of CNS pathologies, but NMDantagonists may elicit side effects including PCP-like psychotomimetic episodes. Early Araxin compouN ...

    SBIRPhase I1995Department of Health and Human Services
  3. NMDA Receptor Antagonists That Spare LTP

    Amount: $76,500.00

    The N-methyl-D-aspartate (NMDA) subtype of glutamate receptor has been implicated in avariety of neurological pathologies including ischemic brain damage (stroke), head trauma, spinal cordinjury, epil ...

    SBIRPhase I1994Department of Health and Human Services
US Flag An Official Website of the United States Government